Patents by Inventor Mikio Ota

Mikio Ota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protecting agent for organ or tissue
    Patent number: 5843969
    Abstract: An agent composition for the therapy or prevention of the injury of an organ or a tissue containing a phenylthiazole derivative expressed by the following formula (1): ##STR1## (R.sub.1 is a C.sub.1 -C.sub.18 alkoxy group or a cyclic amino group; R.sub.2 is a cyano group or a nitro group; R.sub.3 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group), and/or its salt as an active ingredient.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: December 1, 1998
    Assignee: Teijin Limited
    Inventors: Mikio Ota, Hideki Horiuchi, Shigehisa Kitahara, Shiro Kondo, Yasuhiro Takano
  • Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
    Patent number: 5574061
    Abstract: A benzopyran derivative represented by the formula (I) or its pharmaceutically acceptable salt: ##STR1## wherein either one of X and Y stands for the following formula ##STR2## and the other one of X and Y and R.sup.1 -R.sup.10 stand for various substituents,and ACAT inhibitor, anti-hyperlipidemia agent and anti-atherosclerosis agent compositions containing the same as an active ingredient.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: November 12, 1996
    Assignee: Teijin Limited
    Inventors: Tatsuki Shiota, Takumi Takeyasu, Kenichiro Kataoka, Tsutomu Mochizuki, Hirofumi Tanabe, Mikio Ota, Hisao Yamaguchi
  • Benzoxa condensed ring compounds, process for producing the same and pharmaceutical composition comprising the same
    Patent number: 5496853
    Abstract: Pharmaceutical compositions containing a benzoxazole compound and a 2,3-dihydrobenzofuran compound represented by the following formula (I) and its pharmaceutically acceptable salt: ##STR1## In the formula, any one of P, Q, R and S is a group represented by the formula: ##STR2## and R.sub.1, R.sub.2 and the reining three substituents out of the substituents P to S each independently stand for various substituents. These compositions are used as an ATCAT inhibitor or for treating hyperlipidemia and atherosclerosis.
    Type: Grant
    Filed: April 26, 1995
    Date of Patent: March 5, 1996
    Assignee: Teijin Limited
    Inventors: Tatsuki Shiota, Takumi Takeyasu, Kenichiro Kataoka, Tsutomu Mochizuki, Hirofumi Tanabe, Mikio Ota, Masatoshi Kano, Hisao Yamaguchi